查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625409

个人化医疗生物标记市场，规模，占有率，趋势，产业分析报告:各适应症，各用途，各地区 - 市场预测，2025年～2034年

Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，个人化医疗生物标记市场预计到 2034 年将达到 782.7 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于对标靶治疗和精准医学的需求不断增加，个人化医疗生物标记市场正在快速成长。生物标记是用于预测疾病风险、诊断病情和监测治疗反应的生物指标。生物标记的应用涵盖肿瘤学、神经病学、心臟病学和自体免疫疾病等重要领域，在这些领域，个人化方法可以显着改善患者的治疗结果。

市场成长是由生物标记技术的进步所推动的，包括能够开发准确的诊断和治疗解决方案的基因组和蛋白质组创新。癌症、糖尿病和心血管疾病等慢性病的盛行率不断增加，进一步增加了对生物标记的需求，从而促进了早期检测、治疗选择和监测等市场的成长。

製药公司、诊断公司和研究机构之间的策略合作伙伴关係正在加速生物标誌物的开发和采用，为个人化医疗生物标记市场创造重大商机。此外，随着老化社会变得更容易患慢性病和与年龄相关的疾病，对生物标记物的需求不断增长，以便为该族群提供个人化治疗。

个人化医疗生物标记市场报告亮点

从应用来看，由于针对个别患者状况的精准治疗需求不断增加，治疗选择领域在 2024 年占据了最大的市场占有率。

由于全球糖尿病盛行率不断上升，预计基于适应症的糖尿病细分市场在预测期内将出现最高的复合年增长率。

2024年，由于研发方面的大量投资，北美在个人化医疗生物标记市场占据主导地位。

由于慢性病盛行率上升，预计亚太市场在预测期内将显着成长。

全球主要市场企业，Laboratory Corporation of America Holding，Quest Diagnostics Incorporated，Agilent Technologies, Inc.，Genome Medical, Inc.，Coriell Life Sciences，Thermo Fisher Scientific Inc.，NeoGenomics Laboratories，FOUNDATION MEDICINE, INC.，Illumina, Inc.，Guardant 有Health等。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球个人化医疗生物标记市场洞察

  • 市场概述
  • 个人化医疗生物标记市场动态
    • 促进因素和机会
      • 慢性病的盛行率
      • 扩大製药公司和诊断公司之间的合作
    • 阻碍因素与课题
      • 高开发成本
  • PESTEL分析
  • 个人化医疗生物标记市场应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球个人化医疗生物标记市场:各适应症

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 神经学
  • 糖尿病
  • 自体免疫疾病
  • 心臟病
  • 其他

第6章 全球个人化医疗生物标记市场:各用途

  • 主要调查结果
  • 简介
  • 早期发现·筛检
  • 诊断
  • 治疗的选择
  • 监视

第7章 全球个人化医疗生物标记市场:各地区

  • 主要调查结果
  • 简介
    • 个人化医疗生物标记市场评估:各地区，2020年～2034年
  • 北美
    • 北美:各适应症，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各适应症，2020～2034年
    • 欧洲:各用途，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各适应症，2020年～2034年
    • 亚太地区:各用途，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各适应症，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各适应症，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • Laboratory Corporation of America Holding
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Genome Medical, Inc.
  • Coriell Life Sciences.
  • Thermo Fisher Scientific Inc.
  • NeoGenomics Laboratories
  • FOUNDATION MEDICINE, INC.
  • Illumina, Inc.
  • Guardant Health
Product Code: PM5290

The personalized medicine biomarkers market size is expected to reach USD 78.27 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application (Early Detection/Screening, Diagnosis, Treatment Selection, and Monitoring), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine biomarkers market is rapidly growing due to the rising demand for targeted therapies and precision medicine. Biomarkers are biological indicators used to predict disease risk, diagnose conditions, and monitor treatment response. Biomarker applications are across critical areas such as oncology, neurology, cardiology, and autoimmune diseases, where personalized approaches significantly enhance patient outcomes.

Market growth is propelled by advancements in biomarker technologies, including genomic and proteomic innovations, which enable the development of precise diagnostic and therapeutic solutions. The increasing prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases further amplifies the demand for biomarkers, contributing to market growth such as early detection, treatment selection, and monitoring.

Strategic partnerships between pharmaceutical companies, diagnostic firms, and research organizations are accelerating biomarker development and adoption, creating significant personalized medicine biomarkers market opportunities. Furthermore, the aging population is more prone to chronic and age-related conditions, creating a higher demand for biomarkers to personalize treatments for this demographic.

Personalized Medicine Biomarkers Market Report Highlights

In terms of application, in 2024, the treatment selection segment accounted for the largest share of the market due to the growing demand for precision therapies tailored to individual patient profiles.

The diabetes segment, based on indication, is expected to witness the highest CAGR over the forecast period due to the rising global prevalence of diabetes.

In 2024, North America dominated the personalized medicine biomarkers market due to due to significant investments in research and development.

The Asia Pacific market is expected to witness significant growth over the forecast period due to the rising prevalence of chronic diseases.

A few global key market players include Laboratory Corporation of America Holding; Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Genome Medical, Inc.; Coriell Life Sciences; Thermo Fisher Scientific Inc.; NeoGenomics Laboratories; FOUNDATION MEDICINE, INC.; Illumina, Inc.; Guardant Health.

Polaris Market Research has segmented the personalized medicine biomarkers market report on the indication, application, and region:

By Indication Outlook (Revenue, USD Billion; 2020-2034)

  • Oncology
  • By Type
  • § Breast Cancer
  • § Lung Cancer
  • § Colon Cancer
  • § Others
  • By Circulating Biomarkers
  • § Circulating Tumor Cells(CTCs)
  • § Circulating Cell-free DNA(cfDNA)
  • § Extracellular Vesicles (EVs)
  • § Other Circulating Biomarkers
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others

By Application Outlook (Revenue, USD Billion; 2020-2034)

  • Early Detection/Screening
  • Diagnosis
  • Treatment Selection
  • Monitoring

By Regional Outlook (Revenue, USD Billion; 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Personalized Medicine Biomarkers Market Insights

  • 4.1. Personalized Medicine Biomarkers Market - Market Snapshot
  • 4.2. Personalized Medicine Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Rising Collaboration Between Pharmaceutical and Diagnostics Companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Development Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Personalized Medicine Biomarkers Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Personalized Medicine Biomarkers Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Personalized Medicine Biomarkers Market, by Oncology, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Type
      • 5.3.2.1. Global Personalized Medicine Biomarkers Market, by Type, by Region, 2020-2034 (USD Billion)
      • 5.3.2.2. Breast Cancer
      • 5.3.2.2.1. Global Personalized Medicine Biomarkers Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.3. Lung Cancer
      • 5.3.2.3.1. Global Personalized Medicine Biomarkers Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.4. Colon Cancer
      • 5.3.2.4.1. Global Personalized Medicine Biomarkers Market, by Colon Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.5. Others
      • 5.3.2.5.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Circulating Biomarkers
      • 5.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
      • 5.3.3.2. Circulating Tumor Cells(CTCs)
      • 5.3.3.2.1. Global Personalized Medicine Biomarkers Market, by Circulating Tumor Cells(CTCs), by Region, 2020-2034 (USD Billion)
      • 5.3.3.3. Circulating Cell-free DNA(cfDNA)
      • 5.3.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Cell-free DNA(cfDNA), by Region, 2020-2034 (USD Billion)
      • 5.3.3.4. Extracellular Vesicles (EVs)
      • 5.3.3.4.1. Global Personalized Medicine Biomarkers Market, by Extracellular Vesicles (EVs), by Region, 2020-2034 (USD Billion)
      • 5.3.3.5. Other Circulating Biomarkers
      • 5.3.3.5.1. Global Personalized Medicine Biomarkers Market, by Other Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Neurology
    • 5.4.1. Global Personalized Medicine Biomarkers Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 5.5. Diabetes
    • 5.5.1. Global Personalized Medicine Biomarkers Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 5.6. Autoimmune Diseases
    • 5.6.1. Global Personalized Medicine Biomarkers Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 5.7. Cardiology
    • 5.7.1. Global Personalized Medicine Biomarkers Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Personalized Medicine Biomarkers Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Early Detection/Screening
    • 6.3.1. Global Personalized Medicine Biomarkers Market, by Early Detection/Screening, by Region, 2020-2034 (USD Billion)
  • 6.4. Diagnosis
    • 6.4.1. Global Personalized Medicine Biomarkers Market, by Diagnosis, by Region, 2020-2034 (USD Billion)
  • 6.5. Treatment Selection
    • 6.5.1. Global Personalized Medicine Biomarkers Market, by Treatment Selection, by Region, 2020-2034 (USD Billion)
  • 6.6. Monitoring
    • 6.6.1. Global Personalized Medicine Biomarkers Market, by Monitoring, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Biomarkers Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Personalized Medicine Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Personalized Medicine Biomarkers Market - North America
    • 7.3.1. North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.2. North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Personalized Medicine Biomarkers Market - US
      • 7.3.3.1. US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.3.2. US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Personalized Medicine Biomarkers Market - Canada
      • 7.3.4.1. Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Personalized Medicine Biomarkers Market - Europe
    • 7.4.1. Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Personalized Medicine Biomarkers Market - UK
      • 7.4.3.1. UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Personalized Medicine Biomarkers Market - France
      • 7.4.4.1. France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Personalized Medicine Biomarkers Market - Germany
      • 7.4.5.1. Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Personalized Medicine Biomarkers Market - Italy
      • 7.4.6.1. Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Personalized Medicine Biomarkers Market - Spain
      • 7.4.7.1. Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Personalized Medicine Biomarkers Market - Netherlands
      • 7.4.8.1. Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Personalized Medicine Biomarkers Market - Russia
      • 7.4.9.1. Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Personalized Medicine Biomarkers Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Personalized Medicine Biomarkers Market - Asia Pacific
    • 7.5.1. Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Personalized Medicine Biomarkers Market - China
      • 7.5.3.1. China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Personalized Medicine Biomarkers Market - India
      • 7.5.4.1. India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Personalized Medicine Biomarkers Market - Malaysia
      • 7.5.5.1. Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Personalized Medicine Biomarkers Market - Japan
      • 7.5.6.1. Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Personalized Medicine Biomarkers Market - Indonesia
      • 7.5.7.1. Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Personalized Medicine Biomarkers Market - South Korea
      • 7.5.8.1. South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Personalized Medicine Biomarkers Market - Australia
      • 7.5.9.1. Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Personalized Medicine Biomarkers Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Personalized Medicine Biomarkers Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Personalized Medicine Biomarkers Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Personalized Medicine Biomarkers Market - UAE
      • 7.6.4.1. UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Personalized Medicine Biomarkers Market - Israel
      • 7.6.5.1. Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Personalized Medicine Biomarkers Market - South Africa
      • 7.6.6.1. South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Personalized Medicine Biomarkers Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Personalized Medicine Biomarkers Market - Latin America
    • 7.7.1. Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Personalized Medicine Biomarkers Market - Mexico
      • 7.7.3.1. Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Personalized Medicine Biomarkers Market - Brazil
      • 7.7.4.1. Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Personalized Medicine Biomarkers Market - Argentina
      • 7.7.5.1. Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6. Personalized Medicine Biomarkers Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Laboratory Corporation of America Holding
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Quest Diagnostics Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Agilent Technologies, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Genome Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Coriell Life Sciences.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. NeoGenomics Laboratories
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. FOUNDATION MEDICINE, INC.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Illumina, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Guardant Health
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

Table 1 Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 2 Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 3 North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 4 North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 5 US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 6 US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 7 Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 8 Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 9 Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 10 Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 11 UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 12 UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 13 France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 14 France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 15 Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 16 Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 17 Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 18 Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 19 Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 20 Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 21 Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 22 Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 23 Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 24 Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 25 Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 26 Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 27 Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 28 Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 29 China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 30 China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 31 India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 32 India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 33 Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 34 Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 35 Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 36 Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 37 Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 38 Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 39 South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 40 South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 41 Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 42 Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 43 Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 44 Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 45 Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 46 Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 47 Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 48 Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 49 UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 50 UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 51 Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 52 Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 53 South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 54 South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 55 Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 56 Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 57 Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 58 Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 59 Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 60 Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 61 Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 62 Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 63 Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 64 Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 65 Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 66 Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Personalized Medicine Biomarkers Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Indication

Figure 7. Global Personalized Medicine Biomarkers Market, by Indication, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global Personalized Medicine Biomarkers Market, by Application, 2024 & 2034 (USD Billion)